Volume surge · INSM · Healthcare

Insmed Inc (INSM) jumps 33.0% in a heavy-volume week

The biotechnology stock closed at 131.10 USD, with short-term momentum improving even as trend confirmation and relative strength remain weak.

Insmed Inc
Latest131.10 USD
1W move33.0%
Volume1.6x
TrendInactive
Biotechnology lab equipment with a market-data terminal showing generic stock charts and volume bars.

Market update

What happened

Insmed Inc (INSM) rose 33.0% for the week ended Aug. 7, closing at 131.10 USD as activity surged on the active-mover screen. Weekly market data also show a 13.4% four-week gain and a 20.1% twelve-week advance.

The confirming evidence is volume: 29.7 million shares changed hands, above the 13-week average of 18.8 million. The weekly price path over 52 weeks puts the move in medium-term context rather than live intraday action.

The setup is still mixed. The trend signal is inactive, Market Dynamics show slight pressure at -0.07, and Relative Strength is negative at -22.2, leaving the rally without broad technical confirmation.

Continue your research

Explore INSM across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

INSM coverage

Evidence context